DE3876558T2 - Hyposensibilisierend wirksame substanz. - Google Patents

Hyposensibilisierend wirksame substanz.

Info

Publication number
DE3876558T2
DE3876558T2 DE8888308370T DE3876558T DE3876558T2 DE 3876558 T2 DE3876558 T2 DE 3876558T2 DE 8888308370 T DE8888308370 T DE 8888308370T DE 3876558 T DE3876558 T DE 3876558T DE 3876558 T2 DE3876558 T2 DE 3876558T2
Authority
DE
Germany
Prior art keywords
hyposensibilizing
effective substance
substance
effective
hyposensibilizing effective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888308370T
Other languages
English (en)
Other versions
DE3876558D1 (de
Inventor
Tyoku Matsuhashi
Mitsuko Usui
Masakazu Mitsuhashi
Shunsaku Ando
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hayashibara Seibutsu Kagaku Kenkyujo KK
Original Assignee
Hayashibara Seibutsu Kagaku Kenkyujo KK
Hayashibara Biochemical Laboratories Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hayashibara Seibutsu Kagaku Kenkyujo KK, Hayashibara Biochemical Laboratories Co Ltd filed Critical Hayashibara Seibutsu Kagaku Kenkyujo KK
Application granted granted Critical
Publication of DE3876558D1 publication Critical patent/DE3876558D1/de
Publication of DE3876558T2 publication Critical patent/DE3876558T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DE8888308370T 1987-09-12 1988-09-09 Hyposensibilisierend wirksame substanz. Expired - Fee Related DE3876558T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP22878187 1987-09-12
JP63184487A JP2594123B2 (ja) 1987-09-12 1988-07-26 減感作剤

Publications (2)

Publication Number Publication Date
DE3876558D1 DE3876558D1 (de) 1993-01-21
DE3876558T2 true DE3876558T2 (de) 1993-04-29

Family

ID=26502527

Family Applications (2)

Application Number Title Priority Date Filing Date
DE8888308370T Expired - Fee Related DE3876558T2 (de) 1987-09-12 1988-09-09 Hyposensibilisierend wirksame substanz.
DE198888308370T Pending DE308147T1 (de) 1987-09-12 1988-09-09 Hyposensibilisierend wirksame substanz.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE198888308370T Pending DE308147T1 (de) 1987-09-12 1988-09-09 Hyposensibilisierend wirksame substanz.

Country Status (6)

Country Link
US (1) US4939239A (de)
EP (1) EP0308147B1 (de)
JP (1) JP2594123B2 (de)
KR (2) KR970010543B1 (de)
CA (1) CA1333256C (de)
DE (2) DE3876558T2 (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2838800B2 (ja) * 1989-09-02 1998-12-16 株式会社林原生物化学研究所 減感作剤
US6090386A (en) * 1991-07-12 2000-07-18 Griffith; Irwin J. T cell peptides of the CRX JII allergen
WO1993001213A1 (en) * 1991-07-12 1993-01-21 Immulogic Pharmaceutical Corporation Allergenic proteins and peptides from japanese cedar pollen
US6982326B1 (en) * 1991-07-12 2006-01-03 Immulogic Pharmaceutical Corporation Allergenic proteins and peptides from Japanese cedar pollen
JP3149033B2 (ja) * 1991-10-30 2001-03-26 アサヒビール株式会社 ダニ主要アレルゲンＤｅｒ ｆ ＩＩ中のペプチド
NZ246806A (en) * 1992-09-01 1996-09-25 Immulogic Pharma Corp Allergenic proteins and peptides from japanese cedar pollen, recombinant production and compositions
DE69418433T2 (de) * 1993-11-05 1999-10-28 Hayashibara Biochem Lab Allergenisches Polypeptid von japanischen Zederpollen und diese kodierende DNA
JP3512452B2 (ja) * 1993-12-21 2004-03-29 株式会社林原生物化学研究所 ポリペプチドとその製造方法並びに用途
AUPM322393A0 (en) * 1993-12-24 1994-01-27 Austin Research Institute, The Mucin carbohydrate compounds and their use in immunotherapy
JPH07188291A (ja) * 1993-12-27 1995-07-25 Hayashibara Biochem Lab Inc 蛋白質とその製造方法並びに用途
DK0789590T3 (da) * 1994-09-23 2002-11-04 Zonagen Inc Chitosaninduceret immunforstærkning
US5912000A (en) * 1994-09-23 1999-06-15 Zonagen, Inc. Chitosan induced immunopotentiation
US8021667B2 (en) 1994-11-16 2011-09-20 Macfarlane Burnet Institute For Medical Research And Public Health Ltd Compositions for immunotherapy and uses thereof
US6548643B1 (en) 1994-11-16 2003-04-15 Austin Research Institute Antigen carbohydrate compounds and their use in immunotherapy
US6936277B2 (en) * 1995-01-09 2005-08-30 J. Rettenmaier & Soehne Gmbh & Co. Kg Pharmaceutical excipient having improved compressibility
EP1027063B1 (de) 1997-09-29 2009-02-18 The Macfarlane Burnet Institute For Medical Research And Public Health Ltd Mannose-rezeptor tragende zellinie und antigen zusammensetzung
AU777432B2 (en) * 1999-04-15 2004-10-14 Children's Medical Center Corporation Osteopontin-derived chemotactic and inhibitory agents and uses therefor
AU4431600A (en) * 1999-05-11 2000-11-21 Kyowa Hakko Kogyo Co. Ltd. Novel pollen antigen
US20030031675A1 (en) 2000-06-06 2003-02-13 Mikesell Glen E. B7-related nucleic acids and polypeptides useful for immunomodulation
US20050048614A1 (en) * 2000-06-13 2005-03-03 Children's Medical Center Corporation Biosynthetic oncolytic molecules and uses therefor
KR100425253B1 (ko) * 2001-04-18 2004-03-30 주식회사 현대시스콤 무선통신 시스템에서의 순방향 패킷 송수신 방법
JP4180258B2 (ja) * 2001-08-06 2008-11-12 西川ゴム工業株式会社 ＩｇＥ抗体抑制剤および食品
AU2002359721A1 (en) * 2001-12-19 2003-07-09 Bristol-Myers Squibb Company Pichia pastoris formate dehydrogenase and uses therefor
DE10209821A1 (de) * 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung von Proteinen an ein modifiziertes Polysaccharid
DE10209822A1 (de) * 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung niedermolekularer Substanzen an ein modifiziertes Polysaccharid
EP1356826A1 (de) * 2002-04-22 2003-10-29 BIOMAY Produktions- und Handels- Aktiengesellschaft Mikropartikel die Kohlenhydratkugeln enthalten an welche ein Allergen kovalent gebunden sind
JP2004099511A (ja) * 2002-09-09 2004-04-02 Japan Research & Development Association For New Functional Foods 免疫抑制剤および食品
CA2496317C (en) * 2002-09-11 2014-02-18 Fresenius Kabi Deutschland Gmbh Method of producing hydroxyalkyl starch derivatives
DE10242076A1 (de) * 2002-09-11 2004-03-25 Fresenius Kabi Deutschland Gmbh HAS-Allergen-Konjugate
US7923209B2 (en) 2003-03-14 2011-04-12 Anergis, S.A. Allergen peptide fragments and use thereof
WO2005014655A2 (en) * 2003-08-08 2005-02-17 Fresenius Kabi Deutschland Gmbh Conjugates of hydroxyalkyl starch and a protein
BRPI0413450A (pt) * 2003-08-08 2006-10-17 Fresenius Kabi De Gmbh conjugados de hidroxialquil amido e g-csf
JP5396019B2 (ja) * 2004-03-11 2014-01-22 フレゼニウス・カビ・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング ヒドロキシアルキルデンプンとタンパク質とのコンジュゲート
SG151261A1 (en) * 2004-03-11 2009-04-30 Fresenius Kabi De Gmbh Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination
US20100062973A1 (en) * 2005-03-11 2010-03-11 Fresenius Kabi Deutschland Gmbh Production of bioactive glycoproteins from inactive starting material
EP1762250A1 (de) * 2005-09-12 2007-03-14 Fresenius Kabi Deutschland GmbH Konjugate welche durch chemische Ligation zwischen Hydroxyalkylstärken und aktiven Substanzen mit Bildung eines Thiazolidin-Ringes entstehen
CA2624900A1 (en) * 2005-10-04 2007-04-19 The Research Foundation Of State University Of New York Fibronectin polypeptides and methods of use
EP2004805B1 (de) * 2006-03-23 2018-01-24 Orthocell Ltd Tenozyten-zellkultivierungsverfahren
US9095603B2 (en) 2006-04-05 2015-08-04 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Anti-allergy compositions
EP2150281B1 (de) * 2007-04-24 2018-04-11 Orthocell Limited Tenozyten-enthaltende biologische gerüste und behandlung damit
EP2167111A4 (de) * 2007-06-14 2010-06-09 Univ New York State Res Found Polypeptide und anwendungsverfahren
KR20100074177A (ko) 2007-09-10 2010-07-01 유니버시티 오브 매사추세츠 미토콘드리아-표적화된 항-종양 물질
JP5497006B2 (ja) 2008-04-14 2014-05-21 ザ ジェネラル ホスピタル コーポレイション 膵管腺癌の検出および治療のためのプレクチン−１標的化剤
EP2123261A1 (de) * 2008-05-20 2009-11-25 Stallergenes S.A. Speichelklebende Partikelformulierung zur Induzierung von antigenspezifischer Immuntoleranz
US9989533B2 (en) 2009-05-28 2018-06-05 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Anti-TNF induced apoptosis (ATIA) diagnostic markers and therapies
JP5931449B2 (ja) * 2012-01-11 2016-06-08 日東電工株式会社 医薬組成物及びその製造方法
EP2908857B1 (de) * 2012-10-19 2017-08-09 Hal Allergy Holding B.V. Zusammensetzungen zur immuntherapie
KR20170141680A (ko) * 2015-05-01 2017-12-26 닛토덴코 가부시키가이샤 알레르기 백신 조성물
CN110023325B (zh) 2016-10-14 2023-07-04 尼优美特里克斯医疗有限公司 具有提高的生物活性和降低的对嗜中性粒细胞弹性蛋白酶降解易感性的来源于纤连蛋白的肽
US10729741B2 (en) 2017-03-27 2020-08-04 Neomatrix Therapeutics Inc. Methods of treating burns with i.v. cP12 in a window from 2 to 6 hours after injury

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4185090A (en) * 1972-02-02 1980-01-22 Abbott Laboratories Chemically modified endotoxin immunizing agent
EP0058021A3 (de) * 1981-02-06 1982-10-27 Beecham Group Plc Pharmazeutische Präparate

Also Published As

Publication number Publication date
JP2594123B2 (ja) 1997-03-26
EP0308147A1 (de) 1989-03-22
KR19980083429A (ko) 1998-12-05
DE308147T1 (de) 1990-03-01
EP0308147B1 (de) 1992-12-09
DE3876558D1 (de) 1993-01-21
KR890004717A (ko) 1989-05-09
KR100234792B1 (ko) 1999-12-15
US4939239A (en) 1990-07-03
KR970010543B1 (ko) 1997-06-28
JPH01156926A (ja) 1989-06-20
CA1333256C (en) 1994-11-29

Similar Documents

Publication Publication Date Title
DE3876558D1 (de) Hyposensibilisierend wirksame substanz.
DE3880632D1 (de) Kuevette.
DE3881291D1 (de) Sehapparat.
DE3862564D1 (de) Erdanker.
FI77952B (fi) Ljusbaogsrelae.
DE3867976D1 (de) Polymergebundene antioxydationsmittel.
DE3876873D1 (de) Weblitzenuebergabevorrichtung.
DE3785663D1 (de) Loetgeraet.
DE3876304D1 (de) Polysilacylobutasilazane.
DE3870513D1 (de) Tennisball.
DE3877421T2 (de) Polyamidbenzazole.
FI77055B (fi) Vaermegradient-inkubator.
FI890318A (fi) Konstruktionssystem foer inredningar.
DE3879348D1 (de) Fm-cw-radargeraet.
DE3878970D1 (de) Praeparative chromatographiesaeule.
DE3862309D1 (de) Aminomethyltetrahydrofurane.
DE3861694D1 (de) Cyclopropancarboxamide.
DE3853279T2 (de) Laryngoskop.
DE3860307D1 (de) 2-aminomethyltetrahydrofurane.
DE3860710D1 (de) Exklusiv-oder-schaltung.
DE3866770D1 (de) Gerbstoff.
DE3873615D1 (de) Polycyanoarylthioether.
DE3879625T2 (de) Laseroszillator.
DE3867805D1 (de) Paraocclusaler loeffel.
DE3875119D1 (de) Sportschuh.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee